AR040763A1 - Profarmacos de la (n-2- piridil-n-2- hidroxicarbonil-etil) - amida del acido 1- metil-2-(4-amidinofenilaminometil)-- benzimidazol-5-il-carboxilico, su preparacion y su utilizacion como medicamentos - Google Patents
Profarmacos de la (n-2- piridil-n-2- hidroxicarbonil-etil) - amida del acido 1- metil-2-(4-amidinofenilaminometil)-- benzimidazol-5-il-carboxilico, su preparacion y su utilizacion como medicamentosInfo
- Publication number
- AR040763A1 AR040763A1 AR20030102774A ARP030102774A AR040763A1 AR 040763 A1 AR040763 A1 AR 040763A1 AR 20030102774 A AR20030102774 A AR 20030102774A AR P030102774 A ARP030102774 A AR P030102774A AR 040763 A1 AR040763 A1 AR 040763A1
- Authority
- AR
- Argentina
- Prior art keywords
- profarmacos
- hydroxicarbonil
- amidinophenylaminometil
- carboxilico
- piridil
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 125000004429 atom Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Nuevos compuestos de la fórmula general (1) en la cual significan a) R´ un átomo de H, y R un grupo metoxicarbonilo o b) R´ un átomo de H o un grupo alquilo C1-6, y R un grupo hidroxi, incluyendo también los grupos alquilo que contienen más de 2 átomos de C sus isómeros ramificados tales como p.ej., los grupos isopropilo, terc-butilo e isobutilo, sus tautómeros y sus sales, especialmente sus sales fisiológicamente tolerables con ácidos o base inorgánicos u orgánicos, las cuales presentan propiedades valiosas, especialmente un efecto inhibidor de la trombina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10235639A DE10235639A1 (de) | 2002-08-02 | 2002-08-02 | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040763A1 true AR040763A1 (es) | 2005-04-20 |
Family
ID=30469409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030102774A AR040763A1 (es) | 2002-08-02 | 2003-08-01 | Profarmacos de la (n-2- piridil-n-2- hidroxicarbonil-etil) - amida del acido 1- metil-2-(4-amidinofenilaminometil)-- benzimidazol-5-il-carboxilico, su preparacion y su utilizacion como medicamentos |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6900229B2 (es) |
| EP (1) | EP1529041B1 (es) |
| JP (1) | JP4230453B2 (es) |
| KR (1) | KR101110088B1 (es) |
| CN (1) | CN100391957C (es) |
| AR (1) | AR040763A1 (es) |
| AT (1) | ATE342265T1 (es) |
| AU (1) | AU2003255304B2 (es) |
| BR (1) | BR0313179A (es) |
| CA (1) | CA2494024C (es) |
| CY (1) | CY1105734T1 (es) |
| DE (2) | DE10235639A1 (es) |
| DK (1) | DK1529041T3 (es) |
| EA (1) | EA008249B1 (es) |
| ES (1) | ES2274300T3 (es) |
| IL (1) | IL166584A (es) |
| MX (1) | MXPA04012945A (es) |
| PL (1) | PL218430B1 (es) |
| PT (1) | PT1529041E (es) |
| TW (1) | TWI313682B (es) |
| WO (1) | WO2004014894A1 (es) |
| ZA (1) | ZA200409940B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030181488A1 (en) | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
| DE10235639A1 (de) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel |
| DE10339862A1 (de) * | 2003-08-29 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel |
| US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
| DE102005020002A1 (de) * | 2005-04-27 | 2006-11-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Physiologisch verträgliche Salze von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester |
| DE102005025728A1 (de) * | 2005-06-04 | 2006-12-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-Propionsäure-ethylester |
| MX2009000602A (es) * | 2006-07-17 | 2009-01-28 | Boehringer Ingelheim Int | Nuevas indicaciones para los inhibidores directos de la trombina en el campo cardiovascular. |
| AR062057A1 (es) * | 2006-07-17 | 2008-10-15 | Boehringer Ingelheim Int | Uso de los inhibidores directos de la trombina |
| EP1956018A1 (de) * | 2007-02-06 | 2008-08-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Verfahren zur Herstellung eines Benzimidazolderivats |
| CN102875529B (zh) * | 2011-07-15 | 2015-04-22 | 天津药物研究院 | 达比加群的酯衍生物及其制备方法 |
| ES2611610T3 (es) | 2011-07-25 | 2017-05-09 | Develco Pharma Schweiz Ag | Ésteres de ácidos amidoxima-carboxílicos de dabigatrán como profármacos y su utilización como un medicamento |
| CN103420994B (zh) * | 2012-05-24 | 2016-04-06 | 天津药物研究院 | 作为前药的达比加群酯衍生物及其制备方法和用途 |
| WO2014012236A1 (zh) * | 2012-07-19 | 2014-01-23 | 北京普禄德医药科技有限公司 | 达比加群的酯衍生物及其制备方法和用途 |
| CN102766134B (zh) * | 2012-07-19 | 2014-06-25 | 北京普禄德医药科技有限公司 | 达比加群的酯衍生物及其制备方法和用途 |
| WO2016019848A1 (zh) * | 2014-08-06 | 2016-02-11 | 四川海思科制药有限公司 | 一种达比加群硫酯衍生物及其制备方法和在药学上的用途 |
| CN111440149A (zh) * | 2020-03-31 | 2020-07-24 | 浙江美诺华药物化学有限公司 | 一种达比加群酯中间体的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6087380A (en) | 1949-11-24 | 2000-07-11 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions |
| CA2134192A1 (en) * | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
| PE121699A1 (es) * | 1997-02-18 | 1999-12-08 | Boehringer Ingelheim Pharma | Heterociclos biciclicos disustituidos como inhibidores de la trombina |
| US6414008B1 (en) | 1997-04-29 | 2002-07-02 | Boehringer Ingelheim Pharma Kg | Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| DE10235639A1 (de) * | 2002-08-02 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel |
-
2002
- 2002-08-02 DE DE10235639A patent/DE10235639A1/de not_active Withdrawn
-
2003
- 2003-07-28 EA EA200500261A patent/EA008249B1/ru not_active IP Right Cessation
- 2003-07-28 CN CNB038185946A patent/CN100391957C/zh not_active Expired - Fee Related
- 2003-07-28 KR KR1020057001873A patent/KR101110088B1/ko not_active Expired - Fee Related
- 2003-07-28 WO PCT/EP2003/008289 patent/WO2004014894A1/de not_active Ceased
- 2003-07-28 JP JP2004526797A patent/JP4230453B2/ja not_active Expired - Lifetime
- 2003-07-28 BR BR0313179-3A patent/BR0313179A/pt not_active Application Discontinuation
- 2003-07-28 DK DK03784088T patent/DK1529041T3/da active
- 2003-07-28 EP EP03784088A patent/EP1529041B1/de not_active Expired - Lifetime
- 2003-07-28 CA CA2494024A patent/CA2494024C/en not_active Expired - Fee Related
- 2003-07-28 PT PT03784088T patent/PT1529041E/pt unknown
- 2003-07-28 AT AT03784088T patent/ATE342265T1/de active
- 2003-07-28 AU AU2003255304A patent/AU2003255304B2/en not_active Ceased
- 2003-07-28 DE DE50305374T patent/DE50305374D1/de not_active Expired - Lifetime
- 2003-07-28 PL PL373088A patent/PL218430B1/pl unknown
- 2003-07-28 MX MXPA04012945A patent/MXPA04012945A/es active IP Right Grant
- 2003-07-28 ES ES03784088T patent/ES2274300T3/es not_active Expired - Lifetime
- 2003-07-31 US US10/631,645 patent/US6900229B2/en not_active Expired - Lifetime
- 2003-08-01 AR AR20030102774A patent/AR040763A1/es not_active Application Discontinuation
- 2003-08-01 TW TW092121155A patent/TWI313682B/zh not_active IP Right Cessation
-
2004
- 2004-12-08 ZA ZA200409940A patent/ZA200409940B/xx unknown
-
2005
- 2005-01-31 IL IL166584A patent/IL166584A/en not_active IP Right Cessation
- 2005-02-11 US US11/056,029 patent/US7189743B2/en not_active Expired - Lifetime
-
2006
- 2006-10-24 CY CY20061101538T patent/CY1105734T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR040763A1 (es) | Profarmacos de la (n-2- piridil-n-2- hidroxicarbonil-etil) - amida del acido 1- metil-2-(4-amidinofenilaminometil)-- benzimidazol-5-il-carboxilico, su preparacion y su utilizacion como medicamentos | |
| UY27522A1 (es) | Inhibidores de pde9 para tratamiento de trastornos cardiovasculares | |
| UY27181A1 (es) | Derivados de xantina, su preparación y su empleo como medicamentos. | |
| MX9401315A (es) | Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ES2123810T3 (es) | Heterociclos utiles como antagonistas de neuroquinina. | |
| BR0010555A (pt) | Inibidores de neuraminidases | |
| ES2136037B1 (es) | Inhibidores de sulfamida-metaloproteasa | |
| ES2184280T3 (es) | Compuestos de indol como inhibidores de cox-2'. | |
| MX9306303A (es) | Derivados de acidos carboxilicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion. | |
| ECSP066898A (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento | |
| MX9302448A (es) | Derivados iminicos ciclicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos. | |
| MX9404749A (es) | Heterociclos de fenilo como inhibidores de cox-2. | |
| ES2053508T3 (es) | Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos. | |
| AR046118A1 (es) | Procedimiento para la preparacion de compuestos de aminocrotonilo | |
| UY28859A1 (es) | Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento | |
| UY28103A1 (es) | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos | |
| ES2118095T3 (es) | Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ECSP066802A (es) | Nuevas amidas de ácidos carboxílicos como inhibidores del factor xa | |
| ECSP045497A (es) | "difenilazetidinonas sustituidas con grupos acidos, metodo para su producción, medicamentos que comprenden dichos compuestos y su uso" | |
| EA200300523A1 (ru) | Ингибиторы трипептидил пептидазы | |
| AR049883A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparacion, y su empleo como medicamentos | |
| AR029942A1 (es) | Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios | |
| RU2005105564A (ru) | Производные бензимидазола и их применение в качестве пролекарств ингибиторов протонного насоса | |
| AR026338A1 (es) | Dihidrotiazoles policiclicos, provistos en posicion 2 de radicales alquilo sustituidos, procedimiento para su preparacion y su utilizacion comomedicamentos | |
| GT199900081A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |